Leiner’s U.S. OTC Operations Face Regulatory, Competitive Obstacles
This article was originally published in The Tan Sheet
Executive Summary
Leiner Health Products says the process of restarting its U.S. OTC operations is complicated by Dr. Reddy's Laboratories' termination of contracts to supply ingredients it needs to manufacture OTCs